BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,917,000 | +1.6% | 52,364 | -2.0% | 0.01% | +12.5% |
| Q2 2022 | $7,793,000 | +18.4% | 53,423 | -3.7% | 0.01% | +33.3% |
| Q1 2022 | $6,580,000 | -5.4% | 55,489 | +10.0% | 0.01% | +50.0% |
| Q4 2021 | $6,953,000 | +6.8% | 50,449 | +7.6% | 0.00% | 0.0% |
| Q3 2021 | $6,513,000 | +65.0% | 46,887 | +16.2% | 0.00% | +100.0% |
| Q2 2021 | $3,947,000 | +51.2% | 40,353 | +5.7% | 0.00% | +100.0% |
| Q1 2021 | $2,610,000 | -59.1% | 38,192 | -48.7% | 0.00% | -66.7% |
| Q4 2020 | $6,383,000 | +41.7% | 74,478 | +7.5% | 0.00% | 0.0% |
| Q3 2020 | $4,506,000 | -23.3% | 69,314 | -13.8% | 0.00% | -25.0% |
| Q2 2020 | $5,878,000 | +129.0% | 80,393 | +6.6% | 0.00% | +100.0% |
| Q1 2020 | $2,567,000 | -42.4% | 75,401 | -8.0% | 0.00% | -33.3% |
| Q4 2019 | $4,460,000 | +192.5% | 81,928 | +124.1% | 0.00% | +200.0% |
| Q3 2019 | $1,525,000 | -70.9% | 36,551 | -69.5% | 0.00% | -80.0% |
| Q2 2019 | $5,248,000 | +354.8% | 119,842 | +434.9% | 0.01% | +400.0% |
| Q1 2019 | $1,154,000 | +46.4% | 22,405 | +5.1% | 0.00% | 0.0% |
| Q4 2018 | $788,000 | -53.8% | 21,313 | -53.1% | 0.00% | -50.0% |
| Q3 2018 | $1,707,000 | +71.2% | 45,458 | +80.3% | 0.00% | +100.0% |
| Q2 2018 | $997,000 | +55.1% | 25,219 | +1.0% | 0.00% | 0.0% |
| Q1 2018 | $643,000 | +134.7% | 24,969 | +145.5% | 0.00% | – |
| Q4 2017 | $274,000 | -2.8% | 10,169 | +34.5% | 0.00% | – |
| Q3 2017 | $282,000 | – | 7,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |